References
- R. Abraham, N. Singh, A. Mukhopadhyay, S. Basu, V. Bal, S. Rath, (1995). Modulation of immunogenicity and antigenicity of proteins by maleylation to target scavenger receptors on macrophages J. Immunol 154:1–8.
- T. Allen.(1988). Toxicity of drug carriers to the mononuclear phagocyte system Adv. Drug Deliv. Rev. 2:55–67.
- F. Greenwood, W. Hunter, J. Glover.(1963). The preparation of 131I labelled human growth hormone of high specific radioactivity Biochem. J. 89:114–123.
- M. Groenink, P. Swart, S. Broersen, M. Kuipers, D. Meijer, H. Schuitemaker.(1996). Potent inhibition of replication of primary HIV‐1 isolates by negatively charged human serum albumin AIDS Res. Human. Retrovirol
- G. Harms, C. Dijkstra, Y. Lee, M. Hardonk.(1990). Glycosyl receptors in macrophage subpopularions of rat spleen and lymph node. A comparative study using neogly‐coproteins and monoclonal antibodies EDI, ED2 and ED3 Cell Tissue Res. 262:35–40.
- R. Jansen, G. Molema, R. Pauwels, D. Schols, E. De Clercq, D. Meijer.(1991). Potent in vitro anti‐human immunodeficiency virus‐1 activity of modified human serum albumins Mol. Pharmacol. 39:818–823.
- R. Jansen, D. Schols, R. Pauwels, E. De Clercq, D. Meÿer.(1993a). Novel, negatively charged, human serum albumins display potent and selective in vitro anti‐human immunodeficiency virus Type I activity Mol. Pharmacol. 44:1003–1007.
- R. Jansen, P. Olinga, G. Harms, D. Meijer.(1993b). Pharmacokinetic analysis and cellular distribution of the anti‐HIV compound succinylated human serum albumin (Suc‐HSA) in vivo and in the isolated perfused rat liver Pharm. Res. 10:1611–1614.
- A. Jobbágy, K. Király.(1966). Chemical characterization of fluorescein isothiocyanate‐protein conjugates Biochim. Biophys. Acta 124:166–175.
- M. Kuipers, J. Huisman, P. Swart, M. de Béthune, R. Pauwels, E. De Clercq, H. Schuitemaker, D. Meijer.(1996). Mechanism of anti‐HIV activity of negatively charged albumins: biomolecular interaction with the HIV‐1 envelope protein gpl20 J. Acq. Immun. Defic. Synd. Hum. R.
- H. Maeda, N. Ishida, H. Kawauchi, K. Tuzimura.(1969). Reaction of Fluorescein‐isothiocyanate with proteins and aminoacids J. Biochem. (Tokyo) 65:777–783.
- J. Proost, D. Meijer.(1992). MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring Comput. Biol. Med. 22:155–163.
- P. Swart, C. Sue, M. Kuipers, C. Asuncion, S. Josephs, C. Smit, D. Meijer.(1996). The in vitro anti‐HIV efficacy of negatively charged human serum albumin is antagonized by heparin AIDS Res. Human Retrovirol.
- R. Van Lier, J. Boot, A. Verhoeven, E. De Groot, M. Brouwer, L. Aarden.(1987). Functional studies with anti‐CD3 heavy chain isotype switch variant monoclonal antibodies J. Immunol. 139:2873–2879.
- R. Van Lier, M. Brouwer, V. Rebel, C. Noesel, L. Aarden.(1989). Immobilized anti‐CD3 monoclonal antibodies induce accessory cell‐independent lymphokine production, proliferation and helper activity in human T lymphocytes Immunology 68:45–50.
- Y. Takakura.M. Hashida.H. Sezaki.(1992). Lymphatic transport of drugs255–277.